Crocs, Inc. CROX
Nasdaq · XNAS · stock · Rubber & Plastics Footwear
Chart by TradingView
5/9
Piotroski F — financial health
3.72
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4.0B | -$81.2M | $2.4B | $659.2M | $1.3B |
| 2024 | $4.1B | $950.1M | $2.4B | $923.1M | $1.8B |
| 2023 | $4.0B | $792.6M | $2.2B | $814.8M | $1.5B |
| 2022 | $3.6B | $540.2M | $1.9B | $499.0M | $817.9M |
| 2021 | $2.3B | $725.7M | $1.4B | $511.2M | $14.1M |
| 2020 | $1.4B | $312.9M | $749.9M | $224.9M | $290.6M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.72 (safe)
- Working capital / assets 0.044
- Retained earnings / assets 0.834
- EBIT / assets 0.036
- Equity / liabilities 0.449
Source: SEC EDGAR filings · CIK 0001334036 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.